Tumor necrosis factor-α -308G/A gene polymorphism in Egyptian children with immune thrombocytopenic purpura

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 5, 2014, Pages 458-463

  El Sissy, Maha H ^a,c   El Sissy, A H ^a   Elanwary, Sherif ^b  

^a NATIONAL CANCER INSTITUTE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Genetic polymorphism; Immune thrombocytopenic purpura; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC TRANSCRIPTION; HEREDITY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; STUDY; TH1 CELL; EGYPT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; INFANT; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; POLYMORPHISM, GENETIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905024455     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000089     Document Type: Article

References (33)

1. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura. Diagnosis and management. Hematol Oncol Clin N Am 2010; 24: 249-273.
2. Yaprak I, Atabay B, Durak I, Turker M, Oniz H, Ozer EA. Variant clinical courses in children with immune thrombocytopenic purpura: sixteen year experience of a single medical center. Turk J Hematol 2010; 27: 147-155.
3. Bergmann AK, Grace RF, Neufeld EJ. Genetic studies in pediatric ITP: outlook, feasibility, and requirements. Ann Hematol 2010; 89: S95-S103.
4. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008; 320: 373-376. (Pubitemid 351555659)
5. Psaila B, Bussel JB. Immune thrombocytopenic purpura. Hematol Oncol Clin N Am 2007; 21: 743-759. (Pubitemid 47102561)
6. Amir A, Gilad O, Yacobovich J, Scheuerman O, Tamary H, Garty BZ. Postvaricella thrombocytopenic purpura. Acta Paediatr 2010; 99: 1385-1388.
7. Akalin E, Murphy B. Gene polymorphisms and transplantation. Curr Opin Immunol 2001; 13: 572-576. (Pubitemid 32817036)
8. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol 2010; 85: 174-180.
9. Andersson J. Cytokines in idiopathic thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998; 424: 61-64. (Pubitemid 28410864)
10. Bidwell JL, Wood NA, Morse HR, Olomolaiye OO, Keen LJ, Laundy GJ. Human cytokine gene nucleotide sequence alignments. Eur J Immunogenet 1999; 26 (Suppl 1): 135-223. (Pubitemid 29195353)
11. Foster CB, Zhu S, Erichsen HC, Lehrnbecher T, Hart ES, Choi E, et al. Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br J Haematol 2001; 113: 596-599. (Pubitemid 32524376)
12. Hajeer AH, Hutchinson IV. Influence of TNF-alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 2001; 62: 1191-1199. (Pubitemid 33032271)
13. Batikhan H, Gokcan MK, Beder E, Akar N, Gerceker OM. Association of the tumor necrosis factor alpha-308G/A polymorphism with nasal polyposis. Eur Arch Otorhinolaryngol 2010; 267: 903-908.
14. Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009; 1792: 163-172.
15. González-Manchón C, Fernández-Pinel M, Arias-Salgado EG, Ferrer M, Alvarez MV, Garcia-Munoz S, et al. Molecular genetic analysis of a compound heterozygote for the glycoprotein (GP) IIb gene associated with Glanzmann's thrombasthenia: disruption of the 674-687 disulfide bridge in GPIIb prevents surface exposure of GPIIb-IIIa complexes. Blood 1999; 93: 866-875. (Pubitemid 29067851)
16. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207.
17. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Proven D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an International Working Group. Blood 2009; 113: 2386-2393.
18. Jrad BB, Chatti A, Laatiri A, Ahmed SB, Romdhane A, Ajimi S, et al. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. Eur J Haematol 2007; 78: 117-122. (Pubitemid 46058873)
19. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007; 3: 521-527. (Pubitemid 47351397)
20. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995-1008.
21. Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993; 21 (Suppl): S423-S435. (Pubitemid 23304332)
22. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167: 257-274. (Pubitemid 29178987)
23. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNFalpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406. (Pubitemid 28410565)
24. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399. (Pubitemid 27368335)
25. Teuffel O, Ethier MC, Beyene J, Sung L. Association between tumor necrosis factor-alpha promoter-308A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis. Crit Care Med 2009; 28: 25-29.
26. Settin A, Hassan H, El-Baz R, Hassan T. Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt. Acta Dermatovenerol Alp Panonica Adriat 2009; 18: 105-112.
27. Gambhir D, Lawrence A, Aggarwal A, Misra R, Mandal SK, Naik S. Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population. Rheumatol Int 2010; 30: 1211-1217.
28. Lin YJ, Chen RH, Wan L, Sheu JC, Huang CM, LinCW, et al. Association of TNF-{alpha} gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus 2009; 18: 974-979.
29. Vural P, Deǧirmencioǧlu S, Parldar-Karpuzoǧlu H, Doǧru-Abbasoǧlu S, Hanagasi HA, Karadaǧ B, et al. The combinations of TNF alpha-308 and IL-6-174 or IL-10-1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease. Acta Neurol Scand 2009; 29: 10-19.
30. Cerri AP, Arosio B, Viazzoli C, Confalonieri R, Vergani C, Annoni G. The-308(G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly. Int J Geriatr Psychiatry 2009; 28: 17-19.
31. Okulu E, İleri T, Çulha VK, Ai{dotless}k FM, Eǧin Y, Uysal Z, et al. The role of tumor necrosis factor-alpha -308 G/A and transforming growth factorbeta 1-915 G/C polymorphisms in childhood idiopathic thrombocytopenic purpura. Turk J Hematol 2011; 28: 170-175.
32. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199. (Pubitemid 27157287)
33. Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T, Pehli{dotless}van S. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets 2011; 2: 588-595.